LILindsey Carrie Ivey

Lindsey Carrie Ivey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lindsey Carrie Ivey has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond the Liver: Fontan-Associated Liver Disease Score as a Predictor of Adverse Cardiac Events and All-Cause Mortality

    by Mollie Westrick, Lindsey C. Ivey, Cheryl L. Raskind-Hood, Fred H. Rodriguez, Medha Kallem, Ryan Ford, Rene Romero, Ryan O. Sheets, Yuting Guo, Abeed Sarker, et al.

  • Open Access

    Electrocardiogram Characteristics and Outcomes in an Adult Congenital Heart Disease Population

    by Seyedeh Somayyeh Mousavi, Cheryl L. Raskind‐Hood, Alexandra Haffner, Chad Robichaux, Lindsey C. Ivey, Reza Sameni, Wendy M. Book

    The electrocardiogram (ECG) is a low‐cost, readily available test that may detect dysrhythmia, chamber enlargement, and ischemia in an acquired heart disease population. Use of resting ECG to predict adverse events in an adult congenital heart disease (ACHD) population is unknown. ECG characteristics, outcomes, and vital status of 8130 adults born between 1945 and 2001 with at least two available ECGs during a 10‐year surveillance period (2010–2019) were evaluated at baseline and at the end of surveillance. Outcomes included cardiac hospitalizations, cardiac surgery or intervention, or death during surveillance. Broad CHD anatomic groups were analyzed as follows: “ left ‐sided,” “ right ‐sided,” “ single ‐ ventricle ,” and “ neither ” to account for differences in loading conditions. Of the cohort, 7.2% died, and 33.0% remained alive without adverse events. ECG parameters associated with mortality include wider QRS duration (QRSd), longer corrected QT (QTc), greater QRS‐T angle, left bundle branch block, and rhythm change. Those who died had longer mean baseline QRSd (107.3 ms vs. 101.83 ms, p < 0.0001) and QTc (434.94 ms vs. 425.20 ms, p = 0.0004). Change in QRSd (∆QRSd) was greater in the deceased group than alive (5.18 ms vs. 2.01 ms, p < 0.0001), and in alive with an adverse event compared to those alive without an event (2.78 ms vs. 0.42 ms, p < 0.0001). Mean QRS‐T angle remained concordant in those without an adverse event but deviated in the adverse event group (5.65° vs. 22.91°) ( p < 0.0001). ECG characteristics and changes over time are associated with adverse cardiac events and mortality in a CHD population. Further study is needed to develop an ECG‐based risk model to identify at‐risk CHD patients.

  • Open Access

    Beyond the Liver: Fontan-Associated Liver Disease Surveillance Results as a Predictor of Adverse Cardiac Events and All-Cause Mortality

    by Mollie Westrick, Lindsey C. Ivey, Cheryl L. Raskind-Hood, Fred H. Rodriguez Iii, Medha Kellam, Ryan M. Ford, Rene Romero, Ryan Sheets, Yuting Guo, Abeed Sarker, et al.

    Background: Routine surveillance for Fontan-associated liver disease (FALD), including hepatic imaging and laboratory studies, is standard care for adolescents and adults with Fontan circulation, yet the prognostic utility of these findings for predicting adverse outcomes remains unknown.Methods: We retrospectively reviewed 368 patients with Fontan circulation who underwent hepatic imaging between 2010 and 2023, linked to state death certificates. FALD severity was classified as severe (abnormal imaging with varices, ascites, or splenomegaly [VAS]), moderate (abnormal laboratory results with or without imaging abnormalities, or splenomegaly with otherwise normal imaging), or mild (normal laboratory results). Associations between surveillance findings and advanced heart failure therapy referral (AHFR) or all-cause mortality were assessed.Results: Median age at initial imaging encounter was 20.6 years; 54.6% were male, 54.1% had a systemic left ventricle, and 17.1% had heterotaxy. FALD was severe in 31.8%, moderate in 48.9%, and mild in 19.3%. AHFR and mortality increased with FALD severity: severe (17.9% AHFR, 20.5% mortality), moderate (12.2%, 10.6%), and mild (2.8%, 2.8%) (p<0.01 and p<0.001, respectively). Laboratory abnormalities were present in 76.1% of those with severe FALD and were independently associated with adverse outcomes. Ten-year overall survival was 96%, 86%, and 67%, and event-free survival was 93%, 74%, and 50%, for mild, moderate, and severe FALD, respectively.Conclusions: FALD severity, classified using routine clinical test results, effectively risk-stratifies Fontan patients for AHFR-free survival and all-cause mortality, providing a clinically accessible framework to guide management and inform timely referral for advanced therapies.

  • Open Access

    Maternal and Fetal Complications Among Pregnant Women with Congenital Heart Disease

    by Shayli Patel, Cheryl L Raskind-Hood, Travis Wilson, Fred H. Rodriguez, Alexandra Haffner, Vijaya Kancherla, Lindsey Carrie Ivey, Wendy M. Book

    Background: Survival to reproductive age is now common among women with congenital heart disease (CHD). Pregnancies to women with CHD may be at higher risk for maternal and fetal complications. This study examines maternal and fetal outcomes among pregnant women with CHD covered by Georgia Medicaid. Methods: This case-control study identified 3,461 pregnant women with CHD, 11-50 years, covered by Georgia Medicaid from 2008-2019, who had 5,904 pregnancies. Maternal and fetal outcomes were determined by ICD-9-CM and ICD-10-CM codes at the encounter level. The association of select covariables, including race/ethnicity, social deprivation, CHD native anatomy, rurality, and presence of pre-existing maternal comorbidities on maternal and fetal outcomes were analyzed using chi-square. Multivariate logistic regression models adjusting for covariates were conducted. Results: Women with severe CHD had more fetal complications and fetal deaths/stillbirths than women with non-severe CHD (53.9% vs. 50.2% p=0.01 and 4.4% vs. 3.0%, p=0.007, respectively), but no difference in maternal complications were revealed (60.7% vs. 59.9%, p=ns). In multivariate analysis, pregnancies to women with severe CHD were 25% more likely to have fetal complications than pregnancies to women with non-severe CHD (aOR 1.25, 95CI 1.07-1.47). The most common fetal complications by maternal CHD anatomy were fetal distress, fetal growth restriction, and preterm delivery (27.2% vs. 23.1%, 27.6% vs. 19.4%, 23.1% vs. 19.6% for severe vs. non-severe, respectively, p=<0.05). Conclusions: Pregnancies to women with CHD were associated with a high rate of maternal and fetal complications. Fetal complications, fetal death and stillbirth were highest among women with severe CHD.

  • Open Access

    Racial and Ethnic Disparities in Health Care Usage and Death by Neighborhood Poverty Among Individuals With Congenital Heart Defects, 4 US Surveillance Sites, 2011 to 2013

    by Cheryl L. Raskind‐Hood, Vijaya Kancherla, Lindsey C. Ivey, Fred H. Rodriguez, Anaclare M. Sullivan, George K. Lui, Lorenzo Botto, Marcia Feldkamp, Jennifer S. Li, Alfred D'OTtavio, et al.

    Background: Socioeconomic factors may lead to a disproportionate impact on health care usage and death among individuals with congenital heart defects (CHD) by race, ethnicity, and socioeconomic factors. How neighborhood poverty affects racial and ethnic disparities in health care usage and death among individuals with CHD across the life span is not well described. Methods and Results: Individuals aged 1 to 64 years, with at least 1 CHD‐related International Classification of Diseases, Ninth Revision, Clinical Modification ( ICD‐9‐CM ) code were identified from health care encounters between January 1, 2011, and December 31, 2013, from 4 US sites. Residence was classified into lower‐ or higher‐poverty neighborhoods on the basis of zip code tabulation area from the 2014 American Community Survey 5‐year estimates. Multivariable logistic regression models, adjusting for site, sex, CHD anatomic severity, and insurance‐evaluated associations between race and ethnicity, and health care usage and death, stratified by neighborhood poverty. Of 31 542 individuals, 22.2% were non‐Hispanic Black and 17.0% Hispanic. In high‐poverty neighborhoods, non‐Hispanic Black (44.4%) and Hispanic (47.7%) individuals, respectively, were more likely to be hospitalized (adjusted odds ratio [aOR], 1.2 [95% CI, 1.1–1.3]; and aOR, 1.3 [95% CI, 1.2–1.5]) and have emergency department visits (aOR, 1.3 [95% CI, 1.2–1.5] and aOR, 1.8 [95% CI, 1.5–2.0]) compared with non‐Hispanic White individuals. In high poverty neighborhoods, non‐Hispanic Black individuals with CHD had 1.7 times the odds of death compared with non‐Hispanic White individuals in high‐poverty neighborhoods (95% CI, 1.1–2.7). Racial and ethnic disparities in health care usage were similar in low‐poverty neighborhoods, but disparities in death were attenuated (aOR for non‐Hispanic Black, 1.2 [95% CI=0.9–1.7]). Conclusions: Racial and ethnic disparities in health care usage were found among individuals with CHD in low‐ and high‐poverty neighborhoods, but mortality disparities were larger in high‐poverty neighborhoods. Understanding individual‐ and community‐level social determinants of health, including access to health care, may help address racial and ethnic inequities in health care usage and death among individuals with CHD.


  • Open Access

    Supervised Text Classification System Detects Fontan Patients in Electronic Records With Higher Accuracy Than ICD Codes

    by Yuting Guo, Mohammed A. Al‐Garadi, Wendy M. Book, Lindsey C. Ivey, Fred H. Rodriguez, Cheryl L. Raskind‐Hood, Chad Robichaux, Abeed Sarker

    Background: The Fontan operation is associated with significant morbidity and premature mortality. Fontan cases cannot always be identified by International Classification of Diseases ( ICD ) codes, making it challenging to create large Fontan patient cohorts. We sought to develop natural language processing–based machine learning models to automatically detect Fontan cases from free texts in electronic health records, and compare their performances with ICD code–based classification. Methods and Results: We included free‐text notes of 10 935 manually validated patients, 778 (7.1%) Fontan and 10 157 (92.9%) non‐Fontan, from 2 health care systems. Using 80% of the patient data, we trained and optimized multiple machine learning models, support vector machines and 2 versions of RoBERTa (a robustly optimized transformer‐based model for language understanding), for automatically identifying Fontan cases based on notes. For RoBERTa, we implemented a novel sliding window strategy to overcome its length limit. We evaluated the machine learning models and ICD code–based classification on 20% of the held‐out patient data using the F 1 score metric. The ICD classification model, support vector machine, and RoBERTa achieved F 1 scores of 0.81 (95% CI, 0.79–0.83), 0.95 (95% CI, 0.92–0.97), and 0.89 (95% CI, 0.88–0.85) for the positive (Fontan) class, respectively. Support vector machines obtained the best performance ( P ICD code–based classification ( P P ICD code–based classification produced more false positives. Conclusions: Natural language processing models can automatically detect Fontan patients based on clinical notes with higher accuracy than ICD codes, and the former demonstrated the possibility of further improvement.


  • Open Access

    International Classification of Diseases (ICD) Codes for Congenital Heart Defects (CHD) Have Variable and Limited Accuracy for Detecting CHD Cases

    by Lindsey C. Ivey, Fred H. Rodriguez, Haoming Shi, Cohen Chong, Joy Chen, Cheryl Raskind-Hood, Karrie F. Downing, Sherry L. Farr, Wendy M. Book

    Background Administrative data permits analysis of large cohorts but relies on International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification (ICD) codes that may not reflect true congenital heart defects (CHD). Methods 1497 cases with at least one encounter between 1/1/2010 – 12/31/2019 in two healthcare systems (one adult, one pediatric) identified by at least one of 87 ICD CHD codes were validated through chart review for the presence of CHD and CHD anatomic group. Results Inter- and intra-observer reliability averaged > 95%. Positive predictive value (PPV) of ICD codes for CHD was 68.1% (1020/1497) overall, 94.6% (123/130) for cases identified in both healthcare systems, 95.8% (249/260) for severe codes, 52.6% (370/703) for shunt codes, 75.9% (243/320) for valve codes, 73.5% (119/162) for shunt and valve codes, and 75.0% (39/52) for “Other CHD” (7 ICD codes). PPV for cases with >1 unique CHD code was 85.4% (503/589) vs. 56.3% (498/884) for one CHD code. Of cases with secundum atrial septal defect ICD codes 745.5/Q21.1 in isolation, 30.9% (123/398) had a confirmed CHD. Patent foramen ovale was present in 66.2% (316/477) of false positives (FP). The median number of unique CHD-coded encounters was higher for true positives (TP) than FP (2.0; interquartile range [IQR]: 1.0-3.0 vs 1.0; IQR:1.0-1.0, respectively, pConclusion PPV of CHD ICD codes varies by characteristics for detection of CHD by ICD code and anatomic grouping. While an ICD code for severe CHD and/or the presence of a case in more than one data source, regardless of anatomic group, is associated with higher PPV for CHD, most TP cases did not have these characteristics. The development of algorithms to improve accuracy may improve administrative data for CHD surveillance.